Hologic to acquire Gynesonics for $350M

Hologic, Inc. has signed a definitive agreement to acquire Gynesonics, Inc., a privately held medical device company, for approximately $350 million. Gynesonics develops the Sonata System for minimally invasive treatment of uterine fibroids.

“Gynesonics' Sonata System complements our offering and will give GYN surgeons across the globe an expanded range of options to treat women suffering from heavy periods and fibroids.”hologic.com

• 1 source
• hologic.comHologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health | HologicOct 14, 2024

Summarized from public sources; check the original articles before acting on it.